10 Gilead regulatory affairs leaders
Executive Director- Specialty Regulatory Franchise Lead - Oncology, Senior Director, Regulatory Affairs, Advertising and Promotion and Director Regulatory Affairs, Global Labeling are among the current titles held by these Gilead regulatory affairs leaders. A reader can learn how regulatory affairs leaders work at Gilead from people who have held the role.
Professionals to explore
Anupam Talapatra, RAC, PMP, CQA
LinkedInExperience: Global Director of Regulatory Affairs (Precision Medicine), previously IVD Quality Business Partner · Gilead Sciences
Anupam Talapatra has held the title Global Director of Regulatory Affairs (Precision Medicine), previously IVD Quality Business Partner at Gilead Sciences since May 2023, based in the San Francisco Bay Area. Anupam Talapatra was Senior Director, Regulatory Affairs and Quality Assurance at ARK Diagnostics, Inc. from 2021 to 2023 and Senior Director, Regulatory and Quality at Freenome from 2020 to 2021.
Christopher Sichel
LinkedInExperience: Senior Director, Regulatory Affairs, Advertising and Promotion · Gilead Sciences
Christopher Sichel has been Senior Director, Regulatory Affairs, Advertising and Promotion at Gilead Sciences since May 2022. Christopher Sichel was Senior Director, Commercial Regulatory Affairs at Exelixis from 2021 to 2022, Director, Commercial Regulatory Affairs at Exelixis from 2019 to 2021 and Associate Program Director Commercial Regulatory at Genentech from 2017 to 2019.
Hui Wang
LinkedInExperience: Director, Regulatory Affairs · Gilead Sciences
Hui Wang has been Director, Regulatory Affairs at Gilead Sciences since June 2023, based in the New York City Metropolitan Area. At Regeneron, Hui Wang was Associate Director, Regulatory Affairs from 2022 to 2023, Senior Manager, Regulatory Affairs from 2020 to 2021 and Associate Manager, Regulatory Affairs Strategy & Intelligence from 2016 to 2018.
Nazia Fatima, PharmD, MBA
LinkedInExperience: Director Regulatory Affairs, Global Labeling · Gilead Sciences
Nazia Fatima has been Director Regulatory Affairs, Global Labeling at Gilead Sciences since September 2025, based in the Washington DC-Baltimore Area. At Kite Pharma, Nazia Fatima was Director Regulatory Affairs, Advertising and Promotion from 2024 to 2025 and Associate Director, Global Regulatory Affairs, Advertising and Promotion from 2023 to 2024.
Prachi Shah
LinkedInExperience: Executive Director- Specialty Regulatory Franchise Lead - Oncology · Gilead Sciences
Prachi Shah has been Executive Director- Specialty Regulatory Franchise Lead - Oncology at Gilead Sciences since October 2024, based in San Carlos, California. At Gilead Sciences, Prachi Shah was Early Development Regulatory Franchise Lead - Oncology from 2023 to 2024, Senior Director, Regulatory Affairs- Inflammation from 2020 to 2022 and Director, Regulatory Affairs - Liver Diseases from 2018 to 2020.
Ryan McNeely
LinkedInExperience: Senior Director - Regulatory Affairs Human Capital · Gilead Sciences
Ryan McNeely has been Senior Director - Regulatory Affairs Human Capital at Gilead Sciences since June 2025, based in Philadelphia, Pennsylvania. At Gilead Sciences, Ryan McNeely held the titles Director, Regulatory Affairs Human Capital from 2024 to 2025 and Director, Regulatory Affairs Vendor Governance from 2024 to 2025, and was Associate Director - Head of Outsourcing, Regulatory Operations from 2022 to 2024.
Sean Decker, PMP
LinkedInExperience: Director of Regulatory Affairs, Business Operations · Gilead Sciences
Sean Decker has been Director of Regulatory Affairs, Business Operations at Gilead Sciences since December 2025, based in Somerville, New Jersey. At Merck, Sean Decker held the title Associate Principal Scientist, Regulatory Affairs from 2024 to 2025 and was Senior Scientist, Regulatory Affairs, HQ Oncology from 2022 to 2024.
Sheela Trivedi, Pharm.D., CDCES
LinkedInExperience: Director, Regulatory Affairs, Advertising & Promotion · Gilead Sciences
Sheela Trivedi has been Director, Regulatory Affairs, Advertising & Promotion at Gilead Sciences since October 2025, based in Titusville, New Jersey. At Johnson & Johnson Innovative Medicine, Sheela Trivedi held the title Associate Director, Regulatory Advertising & Promotion from 2021 to 2025 and was Medical Information Manager from 2014 to 2021.
Shweta Patel
LinkedInExperience: Director, Regulatory Affairs CMC · Gilead Sciences
Shweta Patel has been Director, Regulatory Affairs CMC at Gilead Sciences since September 2025. At Gilead Sciences, Shweta Patel was Associate Director, Regulatory Affairs CMC from 2024 to 2025, Sr. Manager, Regulatory Affairs from 2022 to 2024 and Manager, Regulatory Affairs CMC from 2019 to 2022, and was Sr. Regulatory Affairs Specialist at Proteus Digital Health, Inc from 2018 to 2019.
Srividya Srikant
LinkedInExperience: Director, Regulatory affairs CMC · Gilead Sciences
Srividya Srikant has been Director, Regulatory affairs CMC at Gilead Sciences since September 2022, based in Jenkintown, Pennsylvania, and the profile headline reads Director Global Regulatory Affairs-CMC. The listing also shows Srividya Srikant in Global Regulatory Affairs-CMC at GSK from 2017 to 2023 and as Sr Scientific Manager at Takeda from 2015 to 2017.
Choose the right perspective
Match the scope in a person's title, such as a regulatory franchise, advertising and promotion review, labeling or regulatory CMC, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Gilead?
- 02What has changed in how you approach regulatory work since you took on your current role?
- 03What has your own work at Gilead taught you about building a regulatory affairs team?
Reaching Gilead regulatory affairs leaders
How can I contact one of these Gilead regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Gilead Sciences, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Gilead regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Gilead regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal